CellPly Company
Developing analytical systems to characterize next-generation cancer immunotherapy
Funding Status:
Seed
Industry:
Preclinical Development
Estimated Revenue:
$1M to $10M
Technology:
Biotechnology, Health Care, Medical
Headquarters:
Bologna, Emilia-Romagna, Italy
Total Funding:
6690000.0
Last Funding Date:
2021-12-15
Last Funding Type:
Venture - Series Unknown
Employee Number:
1-10
Investors Number:
8.0
Founded Date:
2013-01-01